Oliver Lagore Vanvalin Investment Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$13.8K Buy
+171
New +$11.9K 0.01% 389
2024
Q4
$13.4K Buy
171
+8
+5% +$680 ﹤0.01% 406
2024
Q3
$15.3K Hold
163
﹤0.01% 379
2024
Q2
$12.7K Hold
163
﹤0.01% 388
2024
Q1
$14.8K Buy
163
+34
+26% +$2.83K ﹤0.01% 374
2023
Q4
$9.97K Hold
129
﹤0.01% 410
2023
Q3
$8.78K Buy
129
+9
+8% +$655 ﹤0.01% 459
2023
Q2
$9.75K Buy
120
+85
+243% +$6.78K ﹤0.01% 466
2023
Q1
$2.87K Buy
+35
New +$2.5K ﹤0.01% 554

Other funds holding GEHC

Oliver Lagore Vanvalin Investment Group's GEHC Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in GE HealthCare (GEHC) in Q2 2025: 171 shares worth $13.8K. The stake represents 0.01% of the portfolio and ranks #389 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in GEHC as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in GEHC in Q1 2023 and has held it in 9 quarters since. The position peaked at $15.3K in Q3 2024. 1,312 funds tracked by Wall St. Rank hold GEHC as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 171 shares of GE HealthCare worth $13.8K as of Q2 2025.
  • GE HealthCare was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • GE HealthCare made up 0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #389 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in GE HealthCare in Q1 2023 and has held it in 9 quarters since.
  • Oliver Lagore Vanvalin Investment Group's GE HealthCare position peaked at $15.3K in Q3 2024.
  • 1,312 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.